MedPath

Study of association between effect of first EGFR-TKI for EGFR-mutated non-small cell lung cancer and circulating tumor DNA detected with high sensitive analyses for EGFR mutation.

Not Applicable
Conditions
non-small cell lung cancer
Registration Number
JPRN-UMIN000014092
Lead Sponsor
Miyagi CancerCenter
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1.Received EGFR-TKI before this study 2.Interstitial pneumonitis or pulmonary fibrosis apparent on chest X-ray 3.Concomitant other malignancies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath